Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEBATE: B/F/TAF vs DTG+3TC in HIV-positive Patients
NCT04054089Phase 4Completed
- Start
- Jan 2020
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bictegravir, emtricitabine, tenofovir alafenamide, dolutegravir, lamivudine in human immunodeficiency virus infection (HIV). Started Jan 2020; status: completed.
02
Drugs
bictegraviremtricitabinetenofovir alafenamidedolutegravirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04054089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04054089.